| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.006 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.007 |